1-8 of 8
Xu Dong Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737

Free
Keryn M. Lucas, Nethia Mohana-Kumaran, Diana Lau, Xu Dong Zhang, Peter Hersey, David C. Huang, Wolfgang Weninger, Nikolas K. Haass, John D. Allen
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3): 783–795.
https://doi.org/10.1158/1078-0432.CCR-11-1166
Published: 31 January 2012
View article titled, Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737
Open the PDF for Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737 in another window
Includes: Supplementary data
Journal Articles

MEK-Independent Survival of B-RAFV600E Melanoma Cells Selected for Resistance to Apoptosis Induced by the RAF Inhibitor PLX4720

Free
Chen Chen Jiang, Fritz Lai, Rick F. Thorne, Fan Yang, Hao Liu, Peter Hersey, Xu Dong Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (4): 721–730.
https://doi.org/10.1158/1078-0432.CCR-10-2225
Published: 15 February 2011
View article titled, MEK-Independent Survival of B-RAFV600E Melanoma Cells Selected for Resistance to Apoptosis Induced by the RAF Inhibitor PLX4720
Open the PDF for MEK-Independent Survival of B-RAFV600E Melanoma Cells Selected for Resistance to Apoptosis Induced by the RAF Inhibitor PLX4720 in another window
Journal Articles

Metabolic Approaches to Treatment of Melanoma

Free
Peter Hersey, Ralph Neal Watts, Xu Dong Zhang, John Hackett
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (21): 6490–6494.
https://doi.org/10.1158/1078-0432.CCR-09-0251
Published: 02 November 2009
View article titled, Metabolic Approaches to Treatment of Melanoma
Open the PDF for Metabolic Approaches to Treatment of Melanoma in another window
Journal Articles

Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin

Free
Kelly A. Avery-Kiejda, Xu Dong Zhang, Luke J. Adams, Rodney J. Scott, Borivoj Vojtesek, David P. Lane, Peter Hersey
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (6): 1659–1668.
https://doi.org/10.1158/1078-0432.CCR-07-1422
Published: 17 March 2008
View article titled, Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin
Open the PDF for Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin in another window
Includes: Supplementary data
Journal Articles

Apoptosis Induction in Human Melanoma Cells by Inhibition of MEK Is Caspase-Independent and Mediated by the Bcl-2 Family Members PUMA, Bim, and Mcl-1

Free
Yu Fang Wang, Chen Chen Jiang, Kelly Anne Kiejda, Susan Gillespie, Xu Dong Zhang, Peter Hersey
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (16): 4934–4942.
https://doi.org/10.1158/1078-0432.CCR-07-0665
Published: 15 August 2007
View article titled, Apoptosis Induction in Human Melanoma Cells by Inhibition of MEK Is Caspase-Independent and Mediated by the Bcl-2 Family Members PUMA, Bim, and Mcl-1
Open the PDF for Apoptosis Induction in Human Melanoma Cells by Inhibition of MEK Is Caspase-Independent and Mediated by the Bcl-2 Family Members PUMA, Bim, and Mcl-1 in another window
Journal Articles

Docetaxel-Induced Apoptosis of Human Melanoma Is Mediated by Activation of c-Jun NH2-Terminal Kinase and Inhibited by the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway

Free
Nizar M. Mhaidat, Xu Dong Zhang, Chen Chen Jiang, Peter Hersey
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (4): 1308–1314.
https://doi.org/10.1158/1078-0432.CCR-06-2216
Published: 22 February 2007
View article titled, Docetaxel-Induced Apoptosis of Human Melanoma Is Mediated by Activation of c-Jun NH2-Terminal Kinase and Inhibited by the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway
Open the PDF for Docetaxel-Induced Apoptosis of Human Melanoma Is Mediated by Activation of c-Jun NH2-Terminal Kinase and Inhibited by the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway in another window
Journal Articles

Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.

Free
Xu Dong Zhang, Jing Jing Wu, Susan Gillespie, Jodie Borrow, Peter Hersey
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (4): 1355–1364.
https://doi.org/10.1158/1078-0432.CCR-05-2084
Published: 17 February 2006
View article titled, Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Open the PDF for Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. in another window
Journal Articles

Relative Resistance of Fresh Isolates of Melanoma to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis

Free
Tam Nguyen, Xu Dong Zhang, Peter Hersey
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 966s–973s.
Published: 01 March 2001
View article titled, Relative Resistance of Fresh Isolates of Melanoma to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis
Open the PDF for Relative Resistance of Fresh Isolates of Melanoma to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis in another window